Drug development in the field of oncology is mired in tradition, resulting in skyrocketing clinical trial costs that translate into increased costs of health care; the status quo is not sustainable.
Noninvasive Application of Alternating Electric Fields in Glioblastoma: A Fourth Cancer Treatment Modality Adaptive designs are aimed at introducing flexibility in clinical research by allowing ...
The primary goal of the trial was to optimize radiation therapy (RT) dose among three levels (low, standard, and high), given either with placebo (P) or an investigational agent (A), for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results